United States · Venture startup

Who invested in Skyhawk Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 27 Oct 2026

$133Mraised across 1 round since 2021, from 1 source

Latest round
Venture, $133MSept 2021
Investors
4
See who backed them

The rounds

  1. Sept 2021

Founders and team

From Skyhawk Therapeutics's own website: 2 founders.

Bill HaneyCo-Founder, Chief Executive Officer, & Chairman
Kathleen McCarthyCo-Founder & Distinguished Senior Scientist

Everyone who backed them

FidelityVC firm1round
GreatPoint VenturesVC firm1round
Good Growth CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Skyhawk Therapeutics

Who invested in Skyhawk Therapeutics?

Skyhawk Therapeutics's investors include Fidelity, Alexandria Venture Investments, GreatPoint Ventures and Good Growth Capital.

How much has Skyhawk Therapeutics raised?

Skyhawk Therapeutics has raised $133M across 1 round since 2021.

When did Skyhawk Therapeutics last raise?

Skyhawk Therapeutics's most recent round was a Venture of $133M in Sept 2021.

What was Skyhawk Therapeutics's biggest round?

Its most recent round, $133M in Sept 2021, is also its largest on record.

Who backed Skyhawk Therapeutics first?

Skyhawk Therapeutics's first round on record, in Sept 2021, was backed by Fidelity, Alexandria Venture Investments and GreatPoint Ventures and 1 others.

What stage is Skyhawk Therapeutics at?

Skyhawk Therapeutics's latest named round is a Venture, in Sept 2021.

Where is Skyhawk Therapeutics based?

Skyhawk Therapeutics is based in the United States.

Companies like Skyhawk Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.